Grey Wolf Animal Health Corp.

WOLF

CA3978851044

Other Specialty Retailers

Market Closed - Toronto S.E. Other stock markets 01:32:35 2024-07-15 pm EDT			5-day change	1st Jan Change
0.61 ^CAD	0.00%		-1.61%	-17.57%

May. 23	Grey Wolf Animal Health Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Grey Wolf Animal Health Swings To Q3 Profit Vs Year Ago On Higher Revs; Comes As Shares Jumped 6.5% Today	MT

Magen Ventures I Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022

November 07, 2022 at 04:17 pm EST

Magen Ventures I Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was CAD 0.010565 million compared to CAD 0.075133 million a year ago.
For the nine months, net loss was CAD 0.18286 million.

Latest news about Grey Wolf Animal Health Corp.

Grey Wolf Animal Health Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 23	CI
Grey Wolf Animal Health Swings To Q3 Profit Vs Year Ago On Higher Revs; Comes As Shares Jumped 6.5% Today	Nov. 23	MT
Grey Wolf Animal Health Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 23	CI
Murray Roach to Leave Grey Wolf Animal Health Corp. as Chief Commercial Officer	Nov. 01	CI
Grey Wolf Animal Health Posts Q2 Net Income, Revenue Up YOY	23-08-28	MT
Grey Wolf Animal Health Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-28	CI
Grey Wolf Animal Health Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-29	CI
Grey Wolf Animal Health Returns to a First-Quarter Profit on a 17% rise in Sales	23-05-29	MT
Grey Wolf Animal Health Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-24	CI
Grey Wolf Animal Health Returned to a Q4 Profit as Revenue Rises 16%	23-04-24	MT
Grey Wolf Animal Health Corp. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-04-24	CI
Grey Wolf Animal Health Corp. Announces Board Changes	22-11-28	CI
Grey Wolf Animal Health Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-27	CI
Grey Wolf Animal Health Inc. completed the acquisition of Magen Ventures I Inc. (TSXV:MAGN.P) in a reverse merger transaction.	22-11-14	CI
Magen Ventures I Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-07	CI
Grey Wolf Animal Health Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-11-02	CI
Magen Ventures I Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-29	CI
Magen Ventures I Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-27	CI
Magen Ventures I Inc. Reports Earnings Results for the Eleven Months Ended December 31, 2021	22-04-22	CI
Magen Ventures I Inc. Announces Management Changes	22-03-17	CI
Magen Ventures I Inc. Announces Management Changes	22-03-17	CI
Grey Wolf Animal Health Inc. acquired Trutina Pharmacy Inc.	22-03-16	CI
Grey Wolf Animal Health Inc. entered into a non-binding letter of intent to acquire Magen Ventures I Inc. (TSXV:MAGN.P) for CAD 41 million in a reverse merger transaction.	22-01-25	CI
Magen Ventures I Inc. has completed an IPO in the amount of CAD 4 million.	21-06-17	CI
Magen Ventures I Inc. has filed an IPO in the amount of CAD 4 million.	21-04-14	CI

Chart Grey Wolf Animal Health Corp.

Duration

Period

More charts

Company Profile

Grey Wolf Animal Health Corp. is a Canada-based animal health and wellness company. It has a portfolio of products that meets the unmet needs of veterinarians, clinics, and pets. Its segments include the animal health business unit and the pharmacy business unit. The animal health business unit segment primarily focuses on selling, marketing, and distributing pharmaceutical, nutraceutical and consumable products to veterinary clinics across Canada. The pharmacy business unit segment compounds pharmaceuticals, primarily for equine use but also for the bioidentical hormone replacement therapy market, all based on prescriptions received from veterinarians, physicians, and patients. Its product categories include companion animals and equine health. The companion animals product category includes wound care, nutraceuticals, and others. It focuses on in-licensing, acquiring, or developing prescription and non-prescription products for commercialization in the veterinarian channel in Canada.

Sector

Other Specialty Retailers

More about the company

Income Statement Evolution

More financial data

Sector Pet & Pet Supplies Retailers

	1st Jan change	Capi.
GREY WOLF ANIMAL HEALTH CORP.	-17.57%	13.85M
PETS AT HOME GROUP PLC	-4.02%	1.83B
ZOOPLUS SE	+3.70%	1.76B
PET VALU HOLDINGS LTD.	-5.21%	1.41B
MUSTI GROUP OYJ	+2.60%	973M
PETCO HEALTH AND WELLNESS COMPANY, INC.	+12.97%	874M
PET CENTER COMÉRCIO E PARTICIPAÇÕES S.A.	+3.04%	351M
BARK, INC.	+120.98%	307M
HANGZHOU TIANYUAN PET PRODUCTS CO., LTD	-26.68%	270M
WONDER PETS ENTERPRISES CORPORATION	+14.98%	115M